2Takahashi N,Udagawa N,Suda T.A new member of tumor necrosis factor ligand family,ODF/OPGL/TRANCE/RANKL,regulates osteoclast differentiation and function.Biochem Biophys Res Commun.1999;256(3):449-455.
3Hofbauer LC,Khosla S,Dunstan CR,et al.The roles of osteoprotegerin and osteoprotegedn ligand in the paracrine regulation of bone resorption.J Bone Miner Res.2000;15(1):2-12.
4Atmaca A,Kleerekoper M,Bayraktar M,et al.Soy isoflavones in the management of postmenopausal osteoporosis.Menopause.2008;15(4 Pt 1):748-757.
5Vatanparast H,Chilibeck PD.Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype? Nutr Rev.2007;65(6 Pt 1):294-299.
6Cassidy A,Albertazzi P,Lise Nielsen I,et al.Cdtical review of health effects of soyabean phyto-oestrogens in post-menopausal women.Proc Nutr Soc.2006;65(1):76-92.
7Coxam V.Phyto-oestrogens and bone health.Proc Nutr Soc.2008;67(2):184-195.
8Coxam V.Prevention of osteopaenia by phyto-oestrogens:animal studies.Br J Nutr.2003;89 Suppl 1:S75-85.
9Bingham SA,Atkinson C,Liggins J,et al.Phyto-oestrogens:where are we now? Br J Nutr.1998;79(5):393-406.
10Cassidy A.Potential risks and benefits of phytoestrogen-rich diets.Int J Vitam Nutr Res.2003;73(2):120-126.
